$0.64
-0.02 (-2.88%)
Biodel, Inc. (NASDAQ:BIOD)
CAPS Rating:
A specialty pharmaceutical company, which focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes and osteoporosis.
RSS Headlines
Fool UK